Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy
Advanced Science · 2025
DOI: 10.1002/advs.202500967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Mengdan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, Affiliated Hospital of Nantong University, Medical School of NanTong University, Nantong, Jiangsu, 226001, P. R. Ch…. Hauptthemen laut MEDLINE: Cholesterol, Cholesterol Oxidase, Neoplasms, Ultrasonic Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Program, Nantong Natural Science Foundation.
Abstract (Originalsprache)
The inadequate generation of reactive oxygen species (ROS) and metastasis of malignant tumors are critical factors that limit the efficacy of conventional sonodynamic therapy in cancer treatment. Herein, an engineered piezocatalyst: cholesterol oxidase (CHO)‐loaded Pt‐ZnO nanoparticles (Pt‐ZnO/CHO) that can explosively generate large amounts of ROS and block the metastasis of tumor, is developed for improving piezocatalytic tumor therapy. In this process, Pt‐ZnO can substantially generate ROS via initiating ultrasound (US)‐triggered piezocatalytic reactions. In situ‐grown Pt nanoparticles not only optimize piezocatalytic activities but also facilitate oxygen (O 2 ) production, thereby synergistically boosting ROS generation. Moreover, O 2 produced by Pt‐ZnO can accelerate the depletion of excess cholesterol in tumor cells under CHO catalysis to disrupt the integrity of lipid rafts and inhibit the formation of lamellipodia, significantly suppressing the proliferation and metastasis of tumor cells. This strategy by promoting ROS generation and blocking the metastatic pathway of cancer cells offers a new idea for enhanced efficacy‐oriented cancer therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Ultrasound, Affiliated Hospital of Nantong University, Medical School of NanTong University, Nantong, Jiangsu, 226001, P. R. China.
- Department of Ultrasound, The Fourth Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210029, P. R. China.
- Department of Medical Ultrasound, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, P. R. China.
- Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, P.…
ORCID-Profile: Wencheng Wu
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Program
- Nantong Natural Science Foundation
- Postdoctoral Science Foundation
- National Science Foundation for Young Scientists of China
- Medical research project of Jiangsu Provincial Health Commission
Zitieren
APA
Li, M., Zhou, Y., Chen, X., Chen, W., Yang, Y., Qian, C., Yang, L., Zhang, Y., Zhang, Z., Wu, W., & Yin, Y. (2025). Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy. Advanced Science. https://doi.org/10.1002/advs.202500967
Vancouver
Li M, Zhou Y, Chen X, Chen W, Yang Y, Qian C, et al. Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy. Advanced Science. 2025. doi:10.1002/advs.202500967
BibTeX
@article{Li2025,
author = {Li, Mengdan and Zhou, Yajun and Chen, Xiaoyang and Chen, Weiwei and Yang, Yifei and Qian, Cheng and Yang, Lei and Zhang, Yaohan and Zhang, Zheng and Wu, Wencheng and Yin, Yifei},
title = {Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500967}
}
EUVIMED